Arvinas Employee Directory
Biotechnology ResearchConnecticut, United States201-500 Employees
Arvinas is a clinical-stage biotechnology company focused on advancing therapies that degrade disease-causing proteins to treat serious diseases. Using its platform, it designs targeted protein degraders that prompt the body's natural protein disposal system to remove disease-associated proteins. The company is progressing multiple investigational drugs in clinical development, including vepdegestrant for locally advanced or metastatic ER+/HER2- breast cancer, ARV-393 for relapsed or refractory non-Hodgkin lymphoma, and ARV-102 for neurodegenerative disorders. Based in New Haven, Connecticut, Arvinas operates in the biotechnology research sector and employs a workforce described as several hundred people. In 2026, management signaled a shift toward a more selective internal development strategy following its first PROTAC-related approval.